Pterostilbene: What the Research Actually Shows for Cholesterol and Blood Pressure

This blueberry compound gets compared to resveratrol constantly, but the human evidence is thinner than the hype suggests.

Track the foods that fit your goals. Track it free with Ration →

By the Ration Editorial Team · Reviewed against primary research · Updated July 14, 2026

Pterostilbene is a stilbene compound, chemically similar to resveratrol.

It occurs naturally in blueberries, and in smaller amounts in grapes and some Pterocarpus tree bark used in traditional medicine.

Compared to resveratrol, pterostilbene has two methoxy groups instead of hydroxyl groups. This small structural difference is thought to make it more fat soluble and easier for the body to absorb.

Animal studies suggest it may reach and stay in tissues longer than resveratrol, which is one reason researchers have been curious about it as a supplement^[10].

Much of the interest in pterostilbene centers on its antioxidant and anti-inflammatory activity at the cellular level.

In liver cell and animal models, it appears to activate the AMPK and mTOR signaling pathways, along with a protein called Nrf2, which together help regulate fat metabolism and cellular stress responses^[5].

Separate research has looked at its effects on endothelial cells, the cells lining blood vessels, where it may help limit a process called endothelial to mesenchymal transition that contributes to vascular stiffening^[2].

It has also been studied alongside gut microbiota, since polyphenols like pterostilbene are metabolized in part by gut bacteria, which may influence how much of the compound and its byproducts actually reach circulation^[6].

Our database tracks six sources looking at pterostilbene and LDL cholesterol, with a consensus direction toward decrease. The evidence grade is D, meaning the signal is inconsistent or comes mostly from lower quality or preclinical sources.

• ↓LDL CholesterolDPreliminary

  Research may lower LDL Cholesterol · strong agreement · 6 studies

  View 5 studies on PubMed

  • Pterostilbene: Biomedical applications (2013)
  • Interactions between gut microbiota and polyphenols: A mechanistic and metabolomic review (2023)
  • Probiotic-Drug Conjugates Achieve Synchronized Site-Specific Probiotic Colonization and On-Demand Drug Release against Ulcerative Colitis and Its Complication (2025)
  • Nanodrugs Targeting Key Factors of Ferroptosis Regulation for Enhanced Treatment of Osteoarthritis (2025)
  • Effects of Pterostilbene on Diabetes, Liver Steatosis and Serum Lipids (2021)
• ↓Systolic Blood PressureDPreliminary

  Research may lower Systolic Blood Pressure · strong agreement · 6 studies

  View 5 studies on PubMed

  • Blueberries and Honeysuckle Berries: Anthocyanin-Rich Polyphenols for Vascular Endothelial Health and Cardiovascular Disease Prevention (2025)
  • Pharmacokinetics and tissue distribution of pterostilbene in the rat (2014)
  • Serum metabolites of hypertension among Chinese adolescents aged 12-17 years (2022)
  • Resveratrol and pterostilbene attenuated smokeless tobacco induced cardiovascular aberrations in estrogen deficient female rats (2016)
  • Pterostilbene mitigates experimental pulmonary arterial hypertension by inhibiting endothelial-to-mesenchymal transition (2025)

The most directly relevant human data comes from a randomized, double blind, placebo controlled trial that tested pterostilbene on metabolic parameters, including lipids^[11]. Results were mixed, with some markers improving modestly and others not changing significantly.

Animal research has been more consistently favorable. In rat models of diabetes and liver steatosis, pterostilbene supplementation was associated with improvements in serum lipids^[8].

A separate rat study combining pterostilbene with resveratrol found improvements in cardiovascular markers in a model of smokeless tobacco exposure and estrogen deficiency^[9].

Taken together, this is a case where animal data looks encouraging but human trials remain small, few, and inconsistent enough that a D grade feels appropriate.

Systolic blood pressure carries the same D grade evidence rating, based on six sources, with a consensus leaning toward decrease.

Some of the mechanistic support here comes from vascular biology research, including studies on endothelial health and blueberry derived anthocyanins and polyphenols, a class of compounds that includes pterostilbene^[4].

A study in a pulmonary arterial hypertension model found that pterostilbene reduced markers of endothelial dysfunction, supporting a plausible vascular mechanism^[2]. This is a specific and severe form of high blood pressure in the lungs, so it does not directly translate to general blood pressure in healthy adults.

Separately, research into blood pressure among adolescents has explored serum metabolite patterns, including polyphenol related compounds, though this line of work is more about biomarker discovery than testing pterostilbene as an intervention^[7].

The randomized controlled trial in humans did track blood pressure alongside metabolic markers, but did not show dramatic or consistent reductions^[11].

Pterostilbene research extends well beyond cholesterol and blood pressure, though most of this work remains preclinical.

• Osteoarthritis, where nanoparticle delivery systems have been designed to target ferroptosis related cell damage in joint tissue^[1]
• Ulcerative colitis, where engineered probiotic drug conjugates have been tested for site specific delivery in the gut^[3]
• Non alcoholic fatty liver disease (NAFLD), through effects on autophagy and the AMPK/mTOR pathway^[5]
• General antioxidant and anti-inflammatory activity, as reviewed across its broader biomedical applications^[12]

None of these applications are established in humans yet. They represent active areas of laboratory and animal research rather than confirmed benefits.

• Blueberries, the richest common dietary source
• Grapes and grape products in smaller amounts
• Pterocarpus marsupium bark, used traditionally and as a supplement source
• Some other berries in trace amounts

Supplement forms are typically derived from Pterocarpus marsupium extract or synthesized, and are sold as standalone capsules or combined with resveratrol.

The randomized controlled trial in humans used doses in the range of 100 to 250 mg per day over several weeks^[11]. This remains one of the only controlled human dosing studies available.

Pharmacokinetic research in rats suggests pterostilbene is absorbed relatively well and distributed to tissues including the liver, kidney, and eye, though how well this translates to humans is not fully established^[10].

In the limited human trial data, pterostilbene appeared to be generally well tolerated at the doses tested^[11]. Long term safety data at higher doses, or in people with existing health conditions, is not well established.

This article does not offer dosing advice, since appropriate use depends on individual health status and is best discussed with a healthcare provider.

• People interested in polyphenols generally, as part of a diet already rich in berries and other plant foods
• Those tracking research on metabolic health and lipid metabolism, given early animal data^[5][8]
• People curious about vascular health research, given preliminary endothelial studies^[2][4]
• Anyone should weigh the fact that human evidence remains preliminary before making decisions based on pterostilbene specifically

Pterostilbene is a genuinely interesting compound with a plausible biological story, similar in some ways to resveratrol but potentially better absorbed.

For LDL cholesterol and systolic blood pressure, the current evidence grade is D for both, reflecting a consistent direction of effect across animal and mechanistic studies, but limited and mixed human trial support.

Eating pterostilbene rich foods like blueberries fits comfortably into a healthy diet regardless of the supplement question. Treating pterostilbene supplements as a proven cholesterol or blood pressure treatment would be getting ahead of the science.